Adherence to and Dropout from Liraglutide 3.0 mg Obesity Treatment in a Real-World Setting.

Hae-Jin KoJin-Wook KimSoo Lim

Published in: Journal of obesity & metabolic syndrome (2022)

Non-adherence to obesity treatment with liraglutide is related to regular exercise and absence of diabetes mellitus. Further prospective studies are warranted to increase medication adherence in those groups.

Keyphrases

insulin resistance
type diabetes
weight loss
weight gain
physical activity
high fat diet induced
body mass index
adipose tissue
high intensity
combination therapy
skeletal muscle
resistance training
smoking cessation